secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-06-26T13:00:14+00:00
Accession:  0001493152-26-030236
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics announces 1-for-6 reverse stock split effective June 30, 2026 to maintain Nasdaq listing
--------------------------------------------------------------------------------

- Board approved 1-for-6 reverse split; effective 12:01 a.m. ET June 30, 2026; symbol HCWB unchanged.
- Outstanding shares reduce from ~9.58M to ~1.60M; total authorized shares remain 250M.
- Nasdaq Hearings Panel required 20 consecutive trading days >$1.00 by July 29; company met that on June 12.
- Split intended to ensure continued compliance with Bid Price Rule and Panel conditions; CUSIP changes to 40423R303.
- No fractional shares issued; each holder receiving a fractional share instead gets one whole share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/0001493152-26-030236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-030236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer